.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Strane is stocked at 359 licensed dispensaries across Pennsylvania, Maryland, and 3 other states, 117 of them in Pennsylvania, with the deepest coverage in Philadelphia, Pittsburgh, Lancaster, Cranberry Township, and Erie. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Strane’s category mix concentrated 43.88% of sales in Flower with a year-over-year decline of 15.87% and a month-over-month decline of 11.72%, while Vapor Pens at 29.39% share fell 10.50% YoY but rose 12.15% MoM. Pre-Roll expanded to 22.75% share with an 81.42% YoY increase and a 0.78% MoM gain, and Edible held 3.98% share with a 22.07% YoY decline and a 1.26% MoM uptick. With the brand’s average price down 16.97% YoY alongside a Flower-heavy mix and an 8th-place Flower rank in Maryland, the data points to a pivot where Pre-Roll growth offsets Flower pressure while recent momentum concentrates in Vapor Pens.
The mix shift implies Strane is reallocating demand toward value-accessible formats: a 22.75% Pre-Roll share coupled with an 81.42% YoY surge, alongside a 16.97% YoY price decrease at the brand level, signals price elasticity capture, while a 12.15% MoM lift in Vapor Pens against an 11.72% MoM drop in Flower suggests substitution from traditional inhalables to convenience-oriented hardware. Holding 8th in Maryland Flower while Flower share remains 43.88% indicates reliance on a weakening primary pillar; sustaining positioning likely requires continuing to trade consumers into Pre-Roll and Vapor Pens where MoM gains (12.15% in Vapor Pens and 0.78% in Pre-Roll) can buffer Flower’s negative YoY and MoM trajectory.
Competitive Landscape
Strane is ranked #8 in MD Flower in October 2026, unchanged from #8 in October 2025, after sliding from #5 three months ago and down from a peak of #4 in June 2026; in contrast, Fade Co. moved up from #3 to #2 with a 39.3% year-over-year sales increase while RYTHM slipped from #2 to #3 despite an 8.5% year-over-year gain. The top spot remains with SunMed at #1 year over year and in October 2026 even as its sales declined 4.0% year over year, and Evermore Cannabis Company holds #5 with 32.4% year-over-year growth, indicating that Strane’s flat year-over-year rank alongside a quarter-to-date drop from #5 to #8 signals share stability against the field but negative momentum versus faster-rising mid-tier rivals.
Notable Products
Strane spreads sales across many SKUs in October 2026, with the top 10 items contributing 24.1% and the leading product, Juicee J (3.5g), at just 2.9%. That breadth points to a portfolio where no single item carries the load, so sales come from many small contributors rather than a few blockbusters.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
